LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Clinical trials for LEUKEMIA, MYELOMONOCYTIC, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOMONOCYTIC, CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOMONOCYTIC, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to fight aggressive blood cancers
Disease control CompletedThis large, completed Phase 3 trial tested if adding a new drug called pevonedistat to the standard drug azacitidine was better than azacitidine alone. It involved 454 adults with higher-risk forms of myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or low…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 04, 2026 06:05 UTC
-
Experimental pill tested against seven rare blood diseases
Disease control CompletedThis study tested whether an oral medication called dasatinib could help control several rare blood cancers and disorders. Sixty-eight adults with conditions like acute myeloid leukemia, myelofibrosis, and mastocytosis took the pill daily for as long as it worked. Researchers mea…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC